Storia in 20 fonti

Pharma heavyweights clash over anti-obesity drug ads

Danish pharmaceuticals heavyweight Novo Nordisk said Tuesday it is suing its arch US rival, Eli Lilly, over "false and materially misleading" adverts for their competing weight-loss and anti-diabetes…

Raccontata da

forbes.com

biopharmadive.com

www1.folha.uol.com.br

economictimes.indiatimes.com

zerohedge.com

france24.com

lecho.be

fiercepharma.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

france24.comStai leggendo1 mese fa

Pharma heavyweights clash over anti-obesity drug ads

originale

Timeline cronologica

martedì 21 luglio 2026·forbes.com
Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising
The lawsuit, filed in federal court Tuesday, accuses Eli Lilly of using outdated data in advertising campaigns.
martedì 21 luglio 2026·biopharmadive.com
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that…

Pharma heavyweights clash over anti-obesity drug ads

Confronto fonti

Pharma heavyweights clash over anti-obesity drug ads

Timeline cronologica

Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising

Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs

Pharma heavyweights Novo Nordisk and Eli Lilly clash over anti-obesity drug ads

Ozempic maker sues US rival over ad campaign

Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Novo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads

Dona do Ozempic acusa criadora do Mounjaro de fazer propaganda com dados falsos sobre eficácia

Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising

Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads

Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug

GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign

Pharma heavyweights clash over anti-obesity drug ads

Novo Nordisk intente un procès à Eli Lilly pour publicité mensongère sur ses traitements anti-obésité

Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads

Briga das canetas emagrecedoras: dona do Ozempic processa fabricante do Mounjaro nos EUA por propaganda enganosa

Pharmaindustrie: Novo Nordisk verklagt US-Rivalen Eli Lilly

Novo Nordisk porta Eli Lilly in tribunale: pubblicità ingannevole sui farmaci anti-obesità | MilanoFinanza News

Novo Nordisk, fabricante de Ozempic y Wegovy, demanda a Eli Lilly; acusa publicidad engañosa sobre medicamentos contra obesidad y diabetes

L'azienda Novo Nordisk, che produce l'Ozempic, ha fatto causa alla concorrente Eli Lilly per pubblicità ingannevole

Ozempic maker sues US rival over ad campaign

Novo Nordisk, la creadora de Ozempic, demanda a su rival Eli Lilly en Estados Unidos por publicidad engañosa

Novo Nordisk demanda a Eli Lilly por “publicidad engañosa” de Zepbound frente a Ozempic y Wegovy